Understanding Glioblastoma Recurrence
Author Information
Author(s): Shekarian Tala, Ritz Marie-Françoise, Hogan Sabrina, Martins Tomás A, Schmassmann Philip, Gerber Alexandra, Roux Julien, Kaymak Deniz, Durano Célia, Burger Bettina, Matter Matthias, Hutter Gregor
Primary Institution: University of Basel
Hypothesis
This study aimed to characterize longitudinal tumor changes in order to find potentially actionable targets to prevent GBM relapse.
Conclusion
The study identifies specific genes and proteins associated with glioblastoma recurrence, suggesting potential targets for new therapies.
Supporting Evidence
- Activated microglia/macrophages play a role in glioblastoma recurrence.
- Genes involved in synapse development and myelination were differentially expressed between primary and recurrent tumors.
- High expression of FCGRs and complement system genes is associated with short time to relapse in recurrent glioblastoma.
Takeaway
Researchers studied brain tumors to find out why they come back after treatment, hoping to discover new ways to stop this from happening.
Methodology
The study involved RNA and protein extraction from patient-matched primary and recurrent glioblastoma samples, followed by transcriptomics and proteomics analysis.
Potential Biases
Segregating the samples according to time to relapse could lower the chance of detecting a real difference between short and long TTR samples.
Limitations
The small cohort of patient-paired GBM samples and the small tumor fractions studied reduce the confidence of the findings.
Participant Demographics
The study included 18 patients with primary and recurrent glioblastoma, aged 39-65 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website